Mutational spectrum of Gelsolin and its down regulation is associated with breast cancer

Ruqia Mehmood Baig1, Ishrat Mahjabeen, Maimoona Sabir

  • 1Cancer Genetics Lab, Department of Biosciences, COMSATS Institute of Information Technology, Chak shazad, Islamabad, Pakistan. ruqiamehmood@gmail.com

Disease Markers
|January 18, 2013
PubMed

Insights

Gelsolin protein levels are significantly lower in breast tumors, correlating with increased metastasis and mortality. Genetic variations in Gelsolin may contribute to cancer development and progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Gelsolin superfamily proteins regulate actin dynamics, crucial for cellular processes.
  • Gelsolin plays a role in human neoplasia pathogenesis.
  • Understanding Gelsolin's role in breast cancer is vital.

Purpose of the Study:

  • Investigate germline mutations in Gelsolin.
  • Analyze the expressional profile of Gelsolin in human breast cancer tissues.

Main Methods:

  • Germline mutation screening using PCR-SSCP.
  • Gene expression analysis via quantitative real-time PCR.

Main Results:

  • Identified various mutations in Gelsolin coding regions (exons 4, 10, 11, 14, 15), including missense, deletions, insertion, and synonymous substitutions.
  • Gelsolin transcript levels were significantly lower in breast tumor tissues compared to controls (p=0.03).
  • Lower Gelsolin levels correlated with metastasis (p=0.002) and patient mortality (P=0.03).

Conclusions:

  • Gelsolin is downregulated in breast cancer, linked to metastasis and patient survival.
  • Genetic variations in Gelsolin's coding regions may contribute to genetic instability.
  • Gelsolin's expression and genetic variations hold potential significance for breast cancer prognosis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...